Cyclolauranes as plausible chemical scaffold against Naegleria fowleri

Biomed Pharmacother. 2022 May:149:112816. doi: 10.1016/j.biopha.2022.112816. Epub 2022 Mar 11.

Abstract

Primary amoebic meningoencephalitis (PAM) is a central nervous system (CNS) disease caused by Naegleria fowleri that mainly affects children and young adults with fatal consequences in most of the cases. Treatment protocols are based on the combination of different antimicrobial agents, nonetheless there is the need to develop new anti-Naegleria compounds with low toxicity and full effects compared to the currently used drug combination. The marine environment is a well-established source of bioactive natural products. In this work, we have focused on the structure of Laurencia cyclolaurane-type sesquiterpenes as potential chemical model against Naegleria species. The effects of debromolaurinterol (1) to induce PCD/apoptosis-like events in Naegleria fowleri have been evaluated, revealing that this compound induced reduction of ATP production showing a decrease of 99.98% in treated parasite cells. A SAR analysis have been supported with molecular modeling and analysis of the in silico ADME/Tox properties of the Laurencia sesquiterpenes debromolaurinterol (1), laurinterol (2) and allolaurinterol (3), which reinforce cyclolaurane metabolites as plausible molecular models to develop PAM treatments.

Keywords: ATPase; Cyclolaurane; Debromolaurinterol; Laurinterol; Naegleria fowleri; Primary amoebic meningoencephalitis.

MeSH terms

  • Apoptosis
  • Central Nervous System Protozoal Infections* / drug therapy
  • Central Nervous System Protozoal Infections* / parasitology
  • Child
  • Humans
  • Naegleria fowleri*
  • Sesquiterpenes* / pharmacology
  • Sesquiterpenes* / therapeutic use

Substances

  • Sesquiterpenes